Market Tracker

05/27 5:16pm ET

Novavax Inc (NASDAQ:NVAX)

5.86
Delayed Data
As of May 27
 +0.24 / +4.27%
Today’s Change
4.08
Today|||52-Week Range
15.01
-30.15%
Year-to-Date

Today’s Trading

Previous close5.62
Today’s open5.64
Day’s range5.58 - 5.86
Volume3,740,143
Average volume (3 months)6,967,994
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-59.85%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+0.49+1.12%
RDUSRadius Health Inc+1.40+4.16%
OPHTOphthotech Corp+0.25+0.49%
HALOHalozyme Therapeutic...+0.11+1.11%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior Vice President-
Quality Operations
Robert Darius
Corporate headquarters
Gaithersburg, Maryland

Forecasts